Close Menu

NEW YORK (GenomeWeb) – TL Biolabs said today that it recently closed a $4 million round of venture capital financing. The proceeds from the seed round will enable the Santa Clara, California-based company to fund the development and commercial launch of a $15 genomic test for dairy and beef cattle.  

TL Biolabs CEO Fred Turner said in a statement that the firm's new test will "empower farmers to make informed breeding and management decisions and positively impact their bottom line."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.